삼성서울병원

Ko En
의료진 검색
찾으실 의료진명을 입력하여 검색해주세요.

비뇨의학과 전황균 교수

진료분야
전립선암, 로봇수술, PSA(전립선암표지자)이상소견, 방광암, 신장암
진료일정 04 月
날짜
월
01
화
02
수
03
목
04
금
05
토
06
일
07
월
08
화
09
수
10
목
11
금
12
토
13
일
14
월
15
화
16
수
17
목
18
금
19
토
20
일
21
월
22
화
23
수
24
목
25
금
26
토
27
일
28
월
29
화
30
오전
오후
진료일정 05 月
날짜
수
01
목
02
금
03
토
04
일
05
월
06
화
07
수
08
목
09
금
10
토
11
일
12
월
13
화
14
수
15
목
16
금
17
토
18
일
19
월
20
화
21
수
22
목
23
금
24
토
25
일
26
월
27
화
28
수
29
목
30
금
31
오전
오후
본원외래 본원클리닉 본원육아상담 암병원외래 암병원클리닉 암병원육아상담

학력

학력
2010.02 서울대학교 의과대학원 의학과 박사 취득
2004.02 서울대학교 의과대학원 의학과 석사 취득
2000.02 서울대학교 의과대학 의학과 학사 취득

경력

경력
2021.03 ~현재 성균관대학교 의과대학 비뇨기과학 교수
2015.03 ~ 2021.02 성균관대학교 의과대학 비뇨기과학 부교수
2015.08 ~ 2016.07 Stanford University School of Medicine, USA 방문 교수
2013.03 ~ 2015.02 성균관대학교 의과대학 비뇨기과학 조교수
2012.03 ~ 2013.02 삼성서울병원 비뇨의학과 임상조교수
2010.03 ~ 2012.02 차의과학대학교 분당차병원 비뇨의학과 조교수
2009.03 ~ 2010.02 신촌세브란스병원 임상연구조교수
2008.05 ~ 2009.02 서울대학교병원 전임의
2006.05 ~ 2008.04 국군서울지구병원 비뇨의학과 과장
2005.04 ~ 2006.04 육군 제 23사단 58연대 의무중대장
2005.02 비뇨의학과 전문의 자격 취득
2001.03 ~ 2005.02 서울대학교병원 비뇨의학과 전공의 수료
2000.03 ~ 2001.02 서울대학교병원 인턴과정 수료

학회활동

학회활동
2005.03 ~ 현재 대한비뇨기종양학회 정회원
2005.03 ~ 현재 대한비뇨의학회 정회원
2005.03 ~ 현재 대한전립선학회 정회원
논문
  • J ROBOT SURG 2024 10.1007/s11701-023-01779-5 Comparison of perioperative outcomes between robot-assisted adrenalectomy and laparoscopic adrenalectomy: a propensity score matching analysis Lee, CU; Yu, J; Chung, JH; Song, W; Kang, M; Sung, HH; Jeon, HG; Seo, SI; Jeon, SS; Jeong, BC
    View PubMed
  • J MED IMAG RADIAT ON 2024 10.1111/1754-9485.13639 Hypofractionated radiation therapy combined with androgen deprivation therapy for high-risk localized prostate cancer Lee, TH; Pyo, H; Yoo, GS; Jeon, SS; Seo, SI; Jeong, BC; Jeon, HG; Sung, HH; Kang, MY; Song, W; Chung, JH; Bae, BK; Park, W
    View PubMed
  • SCI REP-UK 2024 10.1038/s41598-024-54232-4 Analysis of progression after elective distal ureterectomy and effects of salvage radical nephroureterectomy in patients with distal ureteral urothelial carcinoma Lee, CU; Lee, JH; Lee, HW; Chung, JH; Song, W; Kang, M; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Sung, HH
    View PubMed
  • INT J SURG 2024 10.1097/JS9.0000000000000904 Impact of urinary diversion type on urethral recurrence following radical cystectomy for bladder cancer: propensity score matched and weighted analyses of retrospective cohort Yu, J; Lee, CU; Chung, JH; Song, W; Kang, M; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Sung, HH
    View PubMed
  • J KOREAN MED SCI 2024 10.3346/jkms.2024.39.e63 Sextant Systematic Biopsy Versus Extended 12-Core Systematic Biopsy in Combined Biopsy for Prostate Cancer Chung, JH; Song, W; Kang, MY; Sung, HH; Jeon, HG; Jeong, BC; IL Seo, S; Jeon, SS; Lee, HM; Park, BK
    View PubMed
  • ANAL CHIM ACTA 2024 10.1016/j.aca.2024.342233 Cancer screening through surface-enhanced Raman spectroscopy fingerprinting analysis of urinary metabolites using surface-carbonized silver nanowires on a filter membrane Yu, HJ; Jang, E; Woo, A; Han, IW; Jeon, HG; Linh, VTN; Park, SG; Jung, HS; Lee, MY
    View PubMed
  • FRONT ONCOL 2023 10.3389/fonc.2023.1256153 Use of PIRADS 2.1 to predict capsular invasion in patients with radiologic T3a prostate cancer Song, W; Ko, KJ; Lee, JK; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Chung, JH
    View PubMed
  • PROSTATE INT 2023 10.1016/j.prnil.2023.07.002 Prostate-specific antigen kinetics in hypofractionated radiation therapy alone for intermediate- and high-risk localized prostate cancer Lee, TH; Pyo, H; Yoo, GS; Lee, HM; Jeon, SS; Il Seo, S; Jeong, BC; Jeon, HG; Sung, HH; Kang, M; Song, W; Chung, JH; Bae, BK; Park, W
    View PubMed
  • BIOMEDICINES 2023 10.3390/biomedicines11071912 Comparison of Prostate-Specific Antigen and Its Density and Prostate Health Index and Its Density for Detection of Prostate Cancer Boo, Y; Chung, JH; Kang, MY; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Song, W
    View PubMed
  • PROSTATE INT 2023 10.1016/j.prnil.2022.12.003 Combination of multiparametric magnetic resonance imaging and transperineal template-guided mapping prostate biopsy to determine potential candidates for focal therapy Choi, YH; Lee, CU; Song, W; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Jeon, HG; Lee, SJ
    View PubMed
  • WORLD J MENS HEALTH 2023 10.5534/wjmh.220223 Nomogram Using Prostate Health Index for Predicting Prostate Cancer in the Gray Zone: Prospective, Multicenter Study Chung, JH; Kim, JH; Lee, SW; Park, H; Song, GHY; Song, W; Kang, MY; Sung, HH; Jeon, HG; Jeong, BC; IL Seo, S; Lee, HM; Jeon, SS
    View PubMed
  • INSIGHTS IMAGING 2023 10.1186/s13244-023-01384-y New transperineal ultrasound-guided biopsy for men in whom PSA is increasing after Miles' operation Park, BK; Chung, JH; Song, W; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Kwon, GY
    View PubMed
  • INT J MOL SCI 2023 10.3390/ijms24043994 Fat Loss in Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors Lee, JH; Hwang, S; Jee, B; Kim, JH; Lee, JH; Chung, JH; Song, W; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Park, SH; Kwon, GY; Kang, MY
    View PubMed
  • EUR UROL FOCUS 2023 10.1016/j.euf.2022.09.002 Chromosomal Instability in Cell-free DNA as a Prognostic Biomarker of Metastatic Hormone-sensitive Prostate Cancer Treated with Androgen Deprivation Therapy Lee, CU; Cho, EH; Lee, JN; Lim, JE; Chung, JH; Song, W; Kang, MY; Sung, HH; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Jeon, HG
    View PubMed
  • DIAGNOSTICS 2022 10.3390/diagnostics12102292 A Comparison of Functional and Oncologic Outcomes between Partial Nephrectomy and Radiofrequency Ablation in Patients with Chronic Kidney Disease after Propensity Score Matching Ryoo, H; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Jeon, SS; Lee, HM; Park, BK; Seo, SI
    View PubMed
  • FEBS J 2022 10.1111/febs.16657 Repression of SLC22A3 by the AR-V7/YAP1/TAZ axis in enzalutamide-resistant castration-resistant prostate cancer Seo, E; Jee, B; Chung, JH; Song, W; Sung, HH; Jeon, HG; Jeong, BC; Il Seo, S; Jeon, SS; Lee, HM; Kang, M
    View PubMed
  • CANCERS 2022 10.3390/cancers14174174 Clinical Utility of Prostate Health Index for Diagnosis of Prostate Cancer in Patients with PI-RADS 3 Lesions Lee, CU; Lee, SM; Chung, JH; Kang, MY; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Song, W
    View PubMed
  • J CANCER RES CLIN 2022 10.1007/s00432-022-04243-3 Long-term oncologic outcomes of robot-assisted versus open radical prostatectomy for prostate cancer with seminal vesicle invasion: a multi-institutional study with a minimum 5-year follow-up Suh, J; Jeong, IG; Jeon, HG; Jeong, CW; Lee, S; Jeon, SS; Byun, SS; Kwak, C; Ahn, H
    View PubMed
  • DIAGNOSTICS 2022 10.3390/diagnostics12051040 Utility of Contemporary Health Screening in the Diagnosis of Bladder Cancer Lee, CU; Song, W; Koo, MJ; Boo, Y; Chung, JH; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Lee, HM; Jeong, J; Jeon, S
    View PubMed
  • CANCERS 2022 10.3390/cancers14102497 Robotic Radical Nephroureterectomy with Bladder Cuff Excision for Upper Tract Urothelial Carcinoma: A Trend Analysis of Utilization and a Comparative Study Bae, H; Chung, JH; Song, W; Kang, M; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Sung, HH
    View PubMed
  • CANCERS 2022 10.3390/cancers14102354 Molecular Subtypes Based on Genomic and Transcriptomic Features Correlate with the Responsiveness to Immune Checkpoint Inhibitors in Metastatic Clear Cell Renal Cell Carcinoma Jee, B; Seo, E; Park, K; Kim, YR; Byeon, SJ; Lee, SM; Chung, JH; Song, W; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Park, SH; Park, WY; Kang, MY
    View PubMed
  • INVESTIG CLIN UROL 2022 10.4111/icu.20210434 Feasibility of a deep learning-based diagnostic platform to evaluate lower urinary tract disorders in men using simple uroflowmetry Bang, S; Tukhtaev, S; Ko, KJ; Han, DH; Baek, M; Jeon, HG; Cho, BH; Lee, KS
    View PubMed
  • FRONT ONCOL 2022 10.3389/fonc.2022.874385 A Retrospective Study of First-Line Therapy Involving Immune Checkpoint Inhibitors in Patients With Poor Risk Metastatic Renal Cell Carcinoma Jo, H; Hong, J; Kim, H; Kim, HR; Kwon, GY; Kang, KA; Park, SY; Kim, CK; Park, BK; Chung, JH; Song, W; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Park, SH
    View PubMed
  • PROSTATE INT 2022 10.1016/j.prnil.2021.08.003 Utility of multiple core biopsies during transperineal template-guided mapping biopsy for patients with large prostates and PI-RADS 1-2 on multiparametric magnetic resonance imaging Lee, CU; Chung, JH; Song, W; Kang, MY; Sung, HH; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Jeon, HG
    View PubMed
  • FRONT ONCOL 2022 10.3389/fonc.2021.824204 TRUS-Guided Target Biopsy for a PI-RADS 3-5 Index Lesion to Reduce Gleason Score Underestimation: A Propensity Score Matching Analysis Chung, JH; Park, BK; Song, W; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM
    View PubMed
  • CANCER RES TREAT 2022 10.4143/crt.2020.1373 Risk Factors and Patterns of Locoregional Recurrence after Radical Nephrectomy for Locally Advanced Renal Cell Carcinoma Yoo, GS; Park, W; Pyo, H; Jeong, BC; Jeon, HG; Kang, M; Seo, SI; Jeon, SS; Lee, HM; Choi, HY; Park, BK; Kim, CK; Park, SY; Kwon, GY
    View PubMed
  • CANCERS 2021 10.3390/cancers13246345 Prognostic Impact of Sarcopenia in Patients with Metastatic Hormone-Sensitive Prostate Cancer Lee, JH; Jee, BA; Kim, JH; Bae, H; Chung, JH; Song, W; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Park, SH; Kang, M
    View PubMed
  • BMC CANCER 2021 10.1186/s12885-021-09018-6 A prospective phase-II trial of biweekly docetaxel plus androgen deprivation therapy in patients with previously-untreated metastatic castration-naive prostate cancer Byeon, S; Kim, H; Jeon, HG; Il Seo, S; Jeon, SS; Lee, HM; Il Lee, S; Park, SH
    View PubMed
  • J CLIN MED 2021 10.3390/jcm10214918 Preoperative versus Postoperative Compensation of the Contralateral Normal Kidney in Patients Treated with Radical Nephrectomy for Renal Cell Carcinoma Lee, CU; Ryoo, H; Chung, JH; Song, W; Kang, M; Sung, HH; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Jeon, HG
    View PubMed
  • SCI REP-UK 2021 10.1038/s41598-021-00548-4 Usefulness of MRI targeted prostate biopsy for detecting clinically significant prostate cancer in men with low prostate-specific antigen levels Bang, S; Yu, J; Chung, JH; Song, W; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Lee, HM; Jeon, SS
    View PubMed
  • J CLIN MED 2021 10.3390/jcm10214804 The Role of Prostate Combination Biopsy Consisting of Targeted and Additional Systematic Biopsy Lee, CU; Choi, J; Sung, SH; Chung, JH; Song, W; Kang, M; Sung, HH; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Jeon, HG
    View PubMed
  • SCI REP-UK 2021 10.1038/s41598-021-01003-0 ISL1 promotes enzalutamide resistance in castration-resistant prostate cancer (CRPC) through epithelial to mesenchymal transition (EMT) Choi, JD; Kim, TJ; Jeong, BC; Jeon, HG; Jeon, SS; Kang, MY; Yeom, SY; Seo, SI
    View PubMed
  • FRONT ONCOL 2021 10.3389/fonc.2021.730114 Conditional Intravesical Recurrence-Free Survival Rate After Radical Nephroureterectomy With Bladder Cuff Excision for Upper Tract Urothelial Carcinoma Chung, JH; Song, W; Kang, M; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Sung, HH
    View PubMed
  • CANCER MANAG RES 2021 10.2147/CMAR.S318404 Can Prostate-Specific Antigen Density Be an Index to Distinguish Patients Who Can Omit Repeat Prostate Biopsy in Patients with Negative Magnetic Resonance Imaging? Yu, J; Boo, Y; Kang, M; Sung, HH; Jeong, BC; Seo, S; Jeon, SS; Lee, H; Jeon, HG
    View PubMed
  • CANCER RES TREAT 2021 10.4143/crt.2020.919 Effects of Complete Bladder Cuff Removal on Oncological Outcomes Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma Ryoo, H; Kim, J; Kim, T; Kang, M; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Sung, HH
    View PubMed
  • PLOS ONE 2021 10.1371/journal.pone.0249709 Biochemical recurrence after radical prostatectomy according to nadir prostate specific antigen value Chung1, JH; Jeong, JY; Lee, JY; Song, W; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Lee, HM; Jeon, SS
    View PubMed
  • BIOLOGY-BASEL 2021 10.3390/biology10040297 Assessment of Agreement between Two Difference Prostate-Specific Antigen Assay Modalities Chung1, JH; Park, M; Cho, H; Song, W; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Lee, HM; Jeon, SS
    View PubMed
  • SCI REP-UK 2021 10.1038/s41598-021-87573-5 Comparison of oncologic and functional outcomes between radical nephroureterectomy and segmental ureterectomy for upper urinary tract urothelial carcinoma Kim1, TH; Lee, CU; Kang, M; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Sung, HH
    View PubMed
  • SCI REP-UK 2021 10.1038/s41598-021-85099-4 Potential of circulating tumor DNA as a predictor of therapeutic responses to immune checkpoint blockades in metastatic renal cell carcinoma Kim1, YJ; Kang, Y; Kim, JS; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Park, D; Park, WY; Kang, M
    View PubMed
  • INVESTIG CLIN UROL 2021 10.4111/icu.20200406 Genomic mutation profiling using liquid biopsy in Korean patients with prostate cancer: Circulating tumor DNA mutation predicts the development of castration resistance Yu1, J; Cho, E; Choi, J; Lim, JE; Lee, J; Kang, M; Sung, HH; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Jeon, HG
    View PubMed
  • INVESTIG CLIN UROL 2020 10.4111/icu.20200084 Correlation between Gleason score distribution and Prostate Health Index in patients with prostate-specific antigen values of 2.5-10 ng/mL Choi1, J; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM
    View PubMed
  • INVESTIG CLIN UROL 2020 10.4111/icu.20200214 Docetaxel rechallenge in metastatic castration-resistant prostate cancer A retrospective, single-center study Byeon1, S; Kim, H; Kim, J; Kwon, M; Hur, JY; Jeon, HG; Jeon, SS; Lee, HM; Park, SH
    View PubMed
  • J CANCER 2020 10.7150/jca.48062 Prognostic Impact of Bone Metastasis on Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated by First Line Tyrosine Kinase Inhibitors A Propensity-Score Matching Analysis Kang1, M; Choi, J; Kim, J; Sung, HH; Jeon, HG; Jeong, BC; Jeon, SS; Lee, HM; Park, SH; Song, C; Seo, SI
    View PubMed
  • J KOREAN MED SCI 2020 10.3346/jkms.2020.35.e342 Strategy for Prostate Cancer Patients with Low Prostate Specific Antigen Level (2.5 to 4.0 ng/mL) Chung1, JH; Yu, J; Song, W; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Lee, HM; Jeon, SS
    View PubMed
  • INT J SURG 2020 10.1016/j.ijsu.2020.07.006 Relationship between robotic-assisted radical prostatectomy and retropubic radical prostatectomy in the learning curve of a single surgeon as a novice in radical prostatectomy A retrospective cohort study Song1, W; Lee, SW; Chung, JH; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Lee, HM; Jeon, SS
    View PubMed
  • PROSTATE INT 2020 10.1016/j.prnil.2020.03.003 Detection of prostate cancer using prostate imaging reporting and data system score and prostate-specific antigen density in biopsy-naive and prior biopsy-negative patients Ryoo1, H; Kang, MY; Sung, HH; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Jeon, HG
    View PubMed
  • DIS MARKERS 2020 10.1155/2020/8887605 Clinical Significance of Pre-to-Postoperative Dynamics of Aspartate Transaminase/Alanine Transaminase Ratio in Predicting the Prognosis of Renal Cell Carcinoma after Surgical Treatment Kang1, M; Shin, SJ; Sung, HH; Jeon, HG; Jeong, BC; Jeon, SS; Lee, HM; Seo, SI
    View PubMed
  • CANCERS 2020 10.3390/cancers12040866 Integrative Radiogenomics Approach for Risk Assessment of Post-Operative Metastasis in Pathological T1 Renal Cell Carcinoma: A Pilot Retrospective Cohort Study Lee1, HW; Cho, HH; Joung, JG; Jeon, HG; Jeong, BC; Jeon, SS; Lee, HM; Nam, DH; Park, WY; Kim, CK; Seo, SI; Park, H
    View PubMed
  • CLIN GENITOURIN CANC 2019 10.1016/j.clgc.2019.07.014 Novel Predictive Models of Early Death Less Than 1 Year in Patients With Metastatic Renal Cell Carcinoma After Treatment With First-line Tyrosine Kinase Inhibitors Shin1, SJ; Kim, T; Sung, HH; Jeon, HG; Jeong, BC; Park, SH; Jeon, SS; Lee, HM; Choi, HY; Seo, SI; Kang, M
    View PubMed
  • INVESTIG CLIN UROL 2019 10.4111/icu.2019.60.6.454 The clinical utility of transperineal template-guided saturation prostate biopsy for risk stratification after transrectal ultrasound-guided biopsy Song1, W; Kang, M; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Jeon, HG
    View PubMed
  • J ENDOUROL 2019 10.1089/end.2019.0410 Comparison by Pentafecta Criteria of Transperitoneal and Retroperitoneal Robotic Partial Nephrectomy for Large Renal Tumors Choi1, CI; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Jeon, SS; Lee, HM; Seo, SI
    View PubMed
  • UROL INT 2019 10.1159/000501527 Cancer Location in Upgrading and Detection after Transperineal Template-Guided Mapping Biopsy for Patients in Active Surveillance and Negative Transrectal Ultrasonography-Guided Prostate Biopsy Lee1, CU; Sung, SH; Jang, CT; Kang, M; Sung, HH; Jeong, BC; Il Seo, S; Jeon, SS; Lee, HM; Jeon, HG
    View PubMed
  • CANCER RES TREAT 2019 10.4143/crt.2018.604 Atezolizumab in Patients with Pretreated Urothelial Cancer: A Korean Single-Center, Retrospective Study Hur1, JY; Kim, Y; Kwon, GY; Kang, M; Sung, HH; Jean, HG; Jeong, BC; Seo, SI; Jean, SS; Lee, HM; Lee, SJ; Park, SH
    View PubMed
  • WORLD J UROL 2019 10.1007/s00345-018-02617-2 Combination of multiparametric magnetic resonance imaging and transrectal ultrasound-guided prostate biopsies is not enough for identifying patients eligible for hemiablative focal therapy for prostate cancer Choi1, YH; Yu, JW; Kang, MY; Sung, HH; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Jeon, HG
    View PubMed
  • INVESTIG CLIN UROL 2019 10.4111/icu.2019.60.4.227 Genomic analysis of Korean patients with advanced prostate cancer by use of a comprehensive next-generation sequencing panel and low-coverage, whole-genome sequencing Kang1, M; Cho, E; Jang, J; Lee, J; Jeon, Y; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Choi, HY; Jeon, HG
    View PubMed
  • INT J SURG 2019 10.1016/j.ijsu.2019.04.013 Impact of adjuvant chemotherapy on oncologic outcomes following radical nephroureterectomy for patients with pT3NanyM0 upper tract urothelial carcinoma: A retrospective cohort study Song1, W; Jeong, JY; Jeon, HG; Seo, SI; Jeon, SS; Choi, HY; Lee, HM; Sung, HH
    View PubMed
  • Cancer Manag Res 2019 10.2147/CMAR.S199432 Predictors of postoperative complications after robot-assisted radical cystectomy with extracorporeal urinary diversion Lee1, CU; Kang, M; Kim, TJ; Na, JP; Sung, HH; Jeon, HG; Seo, S; Jeon, SS; Lee, HM; Jeong, BC
    View PubMed
  • PROSTATE 2019 10.1002/pros.23766 A randomized, double-blind, placebo-controlled trial to evaluate the role of curcumin in prostate cancer patients with intermittent androgen deprivation Choi1, YH; Han, DH; Kim, SW; Kim, MJ; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Choi, HY
    View PubMed
  • BMC UROL 2019 10.1186/s12894-019-0463-7 A retrospective feasibility study of biweekly docetaxel in patients with high-risk metastatic castration-naive prostate cancer Yoon1, SE; Kim, Y; Cho, J; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Choi, HY; Lee, SJ; Park, SH
    View PubMed
  • SCI REP-UK 2019 10.1038/s41598-019-42739-0 Transperitoneal radical nephroureterectomy is associated with worse disease progression than retroperitoneal radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma Kim1, TH; Suh, YS; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Choi, HY; Sung, HH
    View PubMed
  • CLIN GENITOURIN CANC 2019 10.1016/j.clgc.2018.09.007 Comparison of Cancer Detection Rates Between TRUS-Guided Biopsy and MRI-Targeted Biopsy According to PSA Level in Biopsy-Naive Patients: A Propensity Score Matching Analysis Choi1, YH; Kang, MY; Sung, HH; Eon, HG; Jeong, BC; Seo, SI; Jeon, SS; Kim, CK; Park, BK; Lee, HM
    View PubMed
  • DIAGN PATHOL 2019 10.1186/s13000-019-0782-8 Histological characteristics of the largest and secondary tumors in radical prostatectomy specimens and implications for focal therapy Choi1, YH; Yu, JW; Jeong, BC; Seo, S; Jeon, SS; Lee, HM; Jeon, HG
    View PubMed
  • Cancer Manag Res 2019 10.2147/CMAR.S185796 Incidences and oncological outcomes of urothelial carcinoma in kidney transplant recipients Yu1, J; Lee, CU; Kang, M; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Sung, HH
    View PubMed
  • CLIN GENITOURIN CANC 2018 10.1016/j.clgc.2018.07.030 Oncologic Outcomes of Cytoreductive Nephrectomy in Synchronous Metastatic Renal-Cell Carcinoma: A Single-Center Experience Choi1, CI; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Jeon, SS; Lee, HM; Seo, SIL
    View PubMed
  • J UROLOGY 2018 10.1016/j.juro.2018.06.030 Changeable Conditional Survival Rates and Associated Prognosticators in Patients with Metastatic Renal Cell Carcinoma Receiving First Line Targeted Therapy Kang1, M; Park, JY; Jeong, CW; Hwang, EC; Song, C; Hong, SH; Kwak, C; Chung, J; Sung, HH; Jeon, HG; Jeong, BC; Park, SH; Jeon, SS; Lee, HM; Choi, HY; Seo, SI
    View PubMed
  • CLIN GENITOURIN CANC 2018 10.1016/j.clgc.2018.02.015 Role of PI-RADS Version 2 for Prediction of Upgrading in Biopsy-Proven Prostate Cancer With Gleason Score 6 Song1, W; Bang, SH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Choi, HY; Kim, CK; Lee, HM
    View PubMed
  • OncoTargets and therapy 2018 10.2147/OTT.S169094 The clinical usefulness of natural killer cell activity in patients with suspected or diagnosed prostate cancer: an observational cross-sectional study Song1, W; Yu, JW; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Choi, HY; Kang, ES; Jeon, HG
    View PubMed
  • EUR RADIOL 2018 10.1007/s00330-018-5305-6 RFA versus robotic partial nephrectomy for T1a renal cell carcinoma: a propensity score-matched comparison of mid-term outcome Park1, BK; Gong, IH; Kang, MY; Sung, HH; Jeon, HG; Jeong, BC; Jeon, SS; Lee, HM; Seo, SI
    View PubMed
  • INT J UROL 2018 10.1111/iju.13574 Prognostic impact of the pretreatment aspartate transaminase/alanine transaminase ratio in patients treated with first-line systemic tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma Kang1, M; Yu, J; Sung, HH; Jeon, HG; Jeong, BC; Park, SH; Jeon, SS; Lee, HM; Choi, HY; Seo, SI
    View PubMed
  • TRANSL ONCOL 2018 10.1016/j.tranon.2017.10.008 Molecular Characterization of Urothelial Carcinoma of the Bladder and Upper Urinary Tract Lee1, JY; Kim, K; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Choi, HY; Kwon, GY; Kim, KM; Lee, J; Lim, HY; Park, SH
    View PubMed
  • J ENDOUROL 2017 10.1089/end.2017.0369 Predictive Factors for Achieving Superior Pentafecta Outcomes Following Robot-Assisted Partial Nephrectomy in Patients with Localized Renal Cell Carcinoma Kang1, M; Gong, IH; Park, HJ; Sung, HH; Jeon, HG; Jeong, BC; Jeon, SS; Lee, HM; Choi, HY; Seo, SI
    View PubMed
  • ANN SURG ONCOL 2017 10.1245/s10434-017-6065-2 y Prognostic Significance of Pre- to Postoperative Dynamics of the Prognostic Nutritional Index for Patients with Renal Cell Carcinoma Who Underwent Radical Nephrectomy Kang1, M; Chang, CT; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Choi, HY; Lee, HM
    View PubMed
  • J CANCER RES CLIN 2017 10.1007/s00432-017-2502-7 Impact of Gleason score on biochemical recurrence in patients with pT3aN0/Nx prostate cancer with positive surgical margins: a multicenter study from the Prostate Cancer Research Committee Song1, W; Lee, DH; Jeon, HG; Jeong, BC; Seo, SI; Lee, HM; Choi, HY; Kim, JW; Lee, S; Byun, SS; Jeong, CW; Kwak, C; Cho, JS; Ahn, H; Jeon, SS
    View PubMed
  • PLoS One 2017 10.1371/journal.pone.0186026 Comparative rates of upstaging and upgrading in Caucasian and Korean prostate cancer patients eligible for active surveillance Jeon1, HG; Yoo, JH; Jeong, BC; Seo, SI; Jeon, SS; Choi, HY; Lee, HM; Ferrari, M; Brooks, JD; Chung, BI
    View PubMed
  • CLIN GENITOURIN CANC 2017 10.1016/j.clgc.2017.04.015 Clinicopathologic Characteristics and Prognosis of Xp11.2 Translocation Renal Cell Carcinoma: Multicenter, Propensity Score Matching Analysis Choo1, MS; Jeong, CW; Song, C; Jeon, HG; Seo, SI; Hong, SK; Byun, SS; Chung, JS; Hong, SH; Hwang, EC; Kim, HH; Kwak, C
    View PubMed
  • SURG ONCOL 2017 10.1016/j.suronc.2017.04.003 Endoscopic management of upper tract urothelial carcinoma: Improved prediction of invasive cancer using a ureteroscopic scoring model Jeon1, SS; Sung, HH; Jeon, HG; Han, DH; Jeong, BC; Seo, SI; Lee, HM; Choi, HY
    View PubMed
  • BMC UROL 2017 10.1186/s12894-017-0253-z A retrospective feasibility study of biweekly, reduced-dose docetaxel in Asian patients with castrate-resistant, metastatic prostate cancer Kim1, HS; Lee, JY; Lee, SJ; Lim, HY; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Choi, HY; Park, SH
    View PubMed
  • CLIN GENITOURIN CANC 2017 10.1016/j.clgc.2017.01.015 Comparison of Oncologic Outcomes and Complications According to Surgical Approach to Radical Prostatectomy: Special Focus on the Perineal Approach Song1, W; Park, JH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Choi, HY
    View PubMed
  • Asian J Androl. 2017 May-Jun;19(3):346-349. doi: 10.4103/1008-682X.172826. Mutation of MED12 is not a frequent occurrence in, prostate cancer of Korean patients Yoon N11, Lim S1, Kang SY1, Kwon GY1, Jeon HG2, Jeong BC2, Seo SI2, Jeon SS2, Lee HM2, Choi HY2.
    View PubMed
  • Urol Oncol. 2017 Mar;35(3):114.e1-114.e7. doi: 10.1016/j.urolonc.2016.10.022. Epub 2016 Nov 28. The effect of contralateral kidney volume on renal function after radical nephroureterectomy: Implications for eligibility for neoadjuvant chemotherapy for upper tract urothelial cancer Song W11, Sung HH1, Han DH1, Jeong BC1, Seo SI1, Jeon SS1, Lee HM1, Choi HY1, Jeon HG2.
    View PubMed
  • Int Urol Nephrol. 2017 Feb;49(2):191-196. doi: 10.1007/s11255-016-1458-x. Epub 2016 Nov 25. Clinical significance of incidentally detected bladder wall thickening on computed tomography Song W11, Jeon HG1, Jeong BC1, Seo SI1, Jeon SS1, Choi HY1, Lee HM2.
    View PubMed
  • Scand J Urol. 2017 Feb;51(1):27-32. doi: 10.1080/21681805.2016.1266384. Development of a new nomogram to predict insignificant prostate cancer in patients undergoing radical prostatectomy Kim TH11, Jeon HG2, Jeong BC2, Seo SI2, Jeon SS2, Choi HY2, Lee HM2.
    View PubMed
  • INTERNATIONAL JOURNAL OF UROLOGY, FEB 2017, 24(2):102-109, DOI: 10.1111/iju.13272 Surgical treatment of renal cell carcinoma: Can morphological features of inferior vena cava tumor thrombus on computed tomography or magnetic resonance imaging be a prognostic factor? Choi DK1, Jeon HG, Jeong CW, Kwak C, Song C, Chung J, Hong SK, Hong SH, Seo S
    View PubMed
  • Oncotarget. 2016 Dec 13;7(50):83735-83743. doi: 10.18632/oncotarget.13407. Immunohistochemical staining of ERG and SOX9 as potential biomarkers of docetaxel response in patients with metastatic castration-resistant prostate cancer Song W11, Kwon GY2, Kim JH3, Lim JE4, Jeon HG1, Il Seo S1, Jeon SS1, Choi HY1, Jeong BC1, Lee HM1.
    View PubMed
  • Can Urol Assoc J. 2016 Nov-Dec;10(11-12):E377-E382. doi: 10.5489/cuaj.3896. Epub 2016 Nov 10. Relationship between Gleason score and apparent diffusion coefficients of diffusion-weighted magnetic resonance imaging in prostate cancer patients Kim TH11, Kim CK2, Park BK2, Jeon HG3, Jeong BC3, Seo SI3, Lee HM3, Choi HY3, Jeon SS3.
    View PubMed
  • Oncotarget. 2016 Sep 27;7(39):63870-63886. doi: 10.18632/oncotarget.11563. Curcumin potentiates antitumor activity of cisplatin in bladder cancer cell lines via ROS-mediated activation of ERK1/2 Park BH11, Lim JE2, Jeon HG3, Seo SI3, Lee HM3, Choi HY3, Jeon SS3, Jeong BC3.
    View PubMed
  • Oncotarget. 2016 Aug 9;7(32):51626-51639. doi: 10.18632/oncotarget.10539. Establishment and antitumor effects of dasatinib and PKI-587 in BD-138T, a patient-derived muscle invasive bladder cancer preclinical platform with concomitant EGFR amplification and PTEN deletion Chang N11,2,3, Lee HW3,4, Lim JE5, Jeong DE1, Song HJ6, Kim S3,7, Nam DH1,2,3, Sung HH5, Jeong BC5, Seo SI5, Jeon SS5, Lee HM5, Choi HY5, Jeon HG5.
    View PubMed
  • J Clin Pathol. 2016 Jul;69(7):586-92. doi: 10.1136/jclinpath-2015-203314. Epub 2015 Dec 15. Correlation of ERG immunohistochemistry with molecular detection of TMPRSS2-ERG gene fusion Sung JY11, Jeon HG2, Jeong BC2, Seo SI2, Jeon SS2, Lee HM2, Choi HY2, Kang SY3, Choi YL3, Kwon GY3.
    View PubMed
  • J Endourol. 2016 Jul;30(7):783-91. doi: 10.1089/end.2015.0652. Epub 2016 May 26. Oncological Outcomes in Patients Treated with Radical Cystectomy for Bladder Cancer: Comparison Between Open, Laparoscopic, and Robot-Assisted Approaches Kim TH11, Sung HH2, Jeon HG2, Seo SI2, Jeon SS2, Lee HM2, Choi HY2, Jeong BC2.
    View PubMed
  • Int J Urol. 2016 Jun;23(6):465-71. doi: 10.1111/iju.13084. Epub 2016 Mar 28. Renal cell carcinoma in end-stage renal disease: Multi-institutional comparative analysis of survival Song C11, Hong SH2, Chung JS3, Byun SS4, Kwak C5, Jeong CW5, Seo SI6, Jeon HG6, Seo IY7.
    View PubMed
  • Int Urol Nephrol. 2016 Jun;48(6):977-83. doi: 10.1007/s11255-016-1250-y. Epub 2016 Feb 26. Tumor size is associated with compensatory hypertrophy in the contralateral kidney after radical nephrectomy in patients with renal cell carcinoma Park BH11, Sung HH2, Jeong BC2, Seo SI2, Jeon SS2, Lee HM2, Choi HY2, Jeon HG3.
    View PubMed
  • Int J Urol. 2016 Jun;23(6):472-7. doi: 10.1111/iju.13077. Epub 2016 Mar 14. Comparison of preoperative adaptive enlargement of the contralateral normal kidney in patients nephrectomized for benign non-functioning kidney versus renal cell carcinoma Song W11, Sung HH1, Han DH1, Jeong BC1, Seo SI1, Jeon SS1, Lee HM1, Choi HY1, Jeon HG1.
    View PubMed
  • UROLOGY, APR 2016, 90:124-125, DOI: 10.1016/j.urology.2015.10.053 Size and Volumetric Growth Kinetics of Renal Masses in Patients With Renal Cell Carcinoma REPLY Lee SW1, Il Seo S
    View PubMed
  • Urology. 2016 Apr;90:119-24. doi: 10.1016/j.urology.2015.10.051. Epub 2016 Jan 11. Size and Volumetric Growth Kinetics of Renal Masses in Patients With Renal Cell Carcinoma Lee SW11, Sung HH1, Jeon HG1, Jeong BC1, Jeon SS1, Lee HM1, Choi HY1, Seo SI2.
    View PubMed
  • J Urol. 2016 Mar;195(3):568-73. doi: 10.1016/j.juro.2015.09.073. Epub 2015 Sep 26. Percutaneous Kidney Biopsy for a Small Renal Mass: A Critical Appraisal of Results Jeon HG11, Seo SI1, Jeong BC1, Jeon SS1, Lee HM1, Choi HY1, Song C1, Hong JH1, Kim CS1, Ahn H1, Jeong IG2.
    View PubMed
  • Ann Surg Oncol. 2016 Jan;23(1):321-7. doi: 10.1245/s10434-015-4614-0. Epub 2015 Jun 5. Preoperative Prognostic Nutritional Index is a Significant Predictor of Survival in Renal Cell Carcinoma Patients Undergoing Nephrectomy Jeon HG11, Choi DK1, Sung HH1, Jeong BC1, Seo SI1, Jeon SS1, Choi HY1, Lee HM2.
    View PubMed
  • Int J Urol. 2016 Jan;23(1):56-61. doi: 10.1111/iju.12960. Epub 2015 Oct 26. Prognostic factors after salvage radiotherapy alone in patients with biochemical recurrence after radical prostatectomy Song W11, Jeon HG1, Sung HH1, Jeong BC1, Seo SI1, Jeon SS1, Choi HY1, Lee HM1.
    View PubMed
  • World J Urol. 2016 Jan;34(1):63-8. doi: 10.1007/s00345-015-1551-2. Epub 2015 Apr 3. Volumetric measurement of compensatory hypertrophy in the contralateral normal kidney by the tumor growth Park BH11, Jeong BC2, Jeon SS2, Seo SI2, Lee HM2, Choi HY2, Jeon HG3.
    View PubMed
  • World J Urol. 2016 Jan;34(1):83-8. doi: 10.1007/s00345-015-1592-6. Epub 2015 May 17. The impact of three-dimensional tumor volume on cancer-specific survival for patients with pT1 clear-cell renal cell carcinoma Song W11, Jeong BC1, Seo SI1, Jeon SS1, Lee HM1, Choi HY1, Jeon HG2.
    View PubMed
  • PLoS One. 2015 Nov 10;10(11):e0139976. doi: 10.1371/journal.pone.0139976. eCollection 2015. Diagnostic Ureterorenoscopy Is Associated with Increased Intravesical Recurrence following Radical Nephroureterectomy in Upper Tract Urothelial Carcinoma Sung HH11, Jeon HG1, Han DH1, Jeong BC1, Seo SI1, Lee HM1, Choi HY1, Jeon SS1.
    View PubMed
  • J Korean Med Sci. 2015 Nov;30(11):1631-7. doi: 10.3346/jkms.2015.30.11.1631. Epub 2015 Oct 16. Is Radical Perineal Prostatectomy a Viable Therapeutic Option for Intermediate- and High-risk Prostate Cancer Lee HW11, Jeon HG2, Jeong BC2, Seo SI2, Jeon SS2, Lee HM2, Choi HY2.
    View PubMed
  • PLoS One. 2015 Nov 24;10(11):e0141709. doi: 10.1371/journal.pone.0141709. eCollection 2015. Trends in the Use of Nephron-Sparing Surgery over 7 Years: An Analysis Using the RENAL Nephrometry Scoring System Shin SJ11, Ko KJ1, Kim TS1, Ryoo HS1, Sung HH1, Jeon HG1, Jeong BC1, Seo SI1, Lee HM1, Choi HY1, Jeon SS1.
    View PubMed
  • Eur Radiol. 2015 Nov;25(11):3143-50. doi: 10.1007/s00330-015-3741-0. Epub 2015 May 8. Measurement of renal function in a kidney donor: a comparison of creatinine-based and volume-based GFRs Choi DK11, Choi SM1, Park BH2, Jeong BC1, Seo SI1, Jeon SS1, Lee HM1, Choi HY1, Jeon HG3.
    View PubMed
  • J Urol. 2015 Oct;194(4):910-5. doi: 10.1016/j.juro.2015.04.093. Epub 2015 Apr 28. Compensatory Structural and Functional Adaptation after Radical Nephrectomy for Renal Cell Carcinoma According to Preoperative Stage of Chronic Kidney Disease Choi DK11, Jung SB1, Park BH1, Jeong BC1, Seo SI1, Jeon SS1, Lee HM1, Choi HY1, Jeon HG2.
    View PubMed
  • J Korean Med Sci. 2015 Sep;30(9):1321-7. doi: 10.3346/jkms.2015.30.9.1321. Epub 2015 Aug 13. Diagnostic and Prognostic Significance of Radiologic Node-positive Renal Cell Carcinoma in the Absence of Distant Metastases: A Retrospective Analysis of Patients Undergoing Nephrectomy and Lymph Node Dissection Lee HW11, Jeon HG2, Jeong BC2, Seo SI2, Jeon SS2, Choi HY2, Lee HM2.
    View PubMed
  • J Korean Med Sci. 2015 Aug;30(8):1150-6. doi: 10.3346/jkms.2015.30.8.1150. Epub 2015 Jul 15. Trends in the Use of Chemotherapy before and after Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer in Korea Kim SH11, Seo HK1, Shin HC1, Chang SJ1, Yun S2, Joo J2, Ku JH3, Kim HS3, Jeon HG4, Jeong BC4, Jeong IG5, Kang SH5, Hong B6; UCART (urothelial cancer-advanced research and treatment group in Korea) group.
    View PubMed
  • Eur Radiol. 2015 Jun;25(6):1786-92. doi: 10.1007/s00330-014-3566-2. Epub 2015 Jan 31. Diffusion-weighted magnetic resonance imaging for prediction of insignificant prostate cancer in potential candidates for active surveillance Kim TH11, Jeong JY, Lee SW, Kim CK, Park BK, Sung HH, Jeon HG, Jeong BC, Seo SI, Lee HM, Choi HY, Jeon SS.
    View PubMed
  • Int J Urol. 2015 May;22(5):455-61. doi: 10.1111/iju.12716. Epub 2015 Jan 29. Prognostic significance of visceral obesity in patients with advanced renal cell carcinoma undergoing nephrectomy Lee HW11, Jeong BC, Seo SI, Jeon SS, Lee HM, Choi HY, Jeon HG.
    View PubMed
  • BJU Int. 2015 Apr;115(4):587-94. doi: 10.1111/bju.12846. Epub 2014 Dec 7. Clinical significance of prognosis using the neutrophil-lymphocyte ratio and erythrocyte sedimentation rate in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma Sung HH11, Jeon HG, Jeong BC, Seo SI, Jeon SS, Choi HY, Lee HM.
    View PubMed
  • PLoS One. 2015 Mar 23;10(3):e0122019. doi: 10.1371/journal.pone.0122019. eCollection 2015. A Comparison of Radiologic Tumor Volume and Pathologic Tumor Volume in Renal Cell Carcinoma (RCC) Choi SM11, Choi DK2, Kim TH2, Jeong BC2, Seo SI2, Jeon SS2, Lee HM2, Choi HY2, Jeon HG3.
    View PubMed
  • J Korean Med Sci. 2015 Mar;30(3):317-22. doi: 10.3346/jkms.2015.30.3.317. Epub 2015 Feb 16. Comparison of Pathological and Biochemical Outcomes after Radical Prostatectomy in Korean Patients with Serum PSA Ranges Lee HW11, Jeon HG1, Jeong BC1, Seo SI1, Jeon SS1, Choi HY1, Lee HM1.
    View PubMed
  • World J Urol. 2014 Dec;32(6):1523-9. doi: 10.1007/s00345-014-1312-7. Epub 2014 May 10. Transperitoneal versus retroperitoneal robotic partial nephrectomy: matched-pair comparisons by nephrometry scores Choo SH11, Lee SY, Sung HH, Jeon HG, Jeong BC, Jeon SS, Lee HM, Choi HY, Seo SI.
    View PubMed
  • J Korean Med Sci. 2014 Dec;29(12):1688-93. doi: 10.3346/jkms.2014.29.12.1688. Epub 2014 Nov 21. Interval from Prostate Biopsy to Radical Prostatectomy Does Not Affect Immediate Operative Outcomes for Open or Minimally Invasive Approach Park B11, Choo SH2, Jeon HG3, Jeong BC3, Seo SI3, Jeon SS3, Lee HM3, Choi HY3.
    View PubMed
  • Urology.?2014 Nov;84(5):1001-7. doi: 10.1016/j.urology.2014.06.052. Epub 2014 Oct 24. Incidence and Management of Extended-spectrum Beta-lactamase and Quinolone-resistant Escherichia coli Infections After Prostate Biopsy Song W11,?Choo SH1,?Sung HH1,?Han DH1,?Jeong BC1,?Seo SI1,?Jeon SS1,?Lee KS1,?Lee SW1,?Lee HM1,?Choi HY1,?Jeon HG2.
    View PubMed
  • J Urol. 2014 Jul;192(1):82-8. doi: 10.1016/j.juro.2014.01.005. Epub 2014 Jan 15. Influence of Magnetic Resonance Imaging in the Decision to Preserve or Resect Neurovascular Bundles at Robotic Assisted Laparoscopic Radical Prostatectomy Park BH11, Jeon HG1, Jeong BC1, Seo SI1, Lee HM1, Choi HY1, Jeon SS2.
    View PubMed
  • BJU Int. 2014 Jun;113(6):864-70. doi: 10.1111/bju.12423. Epub 2013 Dec 2. Role of multiparametric 3.0-Tesla magnetic resonance imaging in patients with prostate cancer eligible for active surveillance Park BH11, Jeon HG, Choo SH, Jeong BC, Seo SI, Jeon SS, Choi HY, Lee HM.
    View PubMed
  • Int J Urol. 2014 Apr;21(4):377-81. doi: 10.1111/iju.12326. Epub 2013 Oct 29. Pathological upgrading and upstaging of patients eligible for active surveillance according to currently used protocols Kim TH11, Jeon HG, Choo SH, Jeong BC, Seo SI, Jeon SS, Choi HY, Lee HM.
    View PubMed
  • Radiother Oncol. 2014 Feb;110(2):240-4. doi: 10.1016/j.radonc.2014.01.001. Epub 2014 Jan 28. Suggestion for the prostatic fossa clinical target volume in adjuvant or salvage radiotherapy after a radical prostatectomy Park JS11, Park W2, Pyo HR1, Park BK3, Park SY3, Choi HY4, Lee HM4, Jeon SS4, Seo SI4, Jeong BC4, Jeon HG4.
    View PubMed
  • J Clin Pathol. 2014 Jan;67(1):49-54. doi: 10.1136/jclinpath-2013-201799. Epub 2013 Aug 12. Clinical significance of micropapillary urothelial carcinoma of the upper urinary tract Sung HH11, Cho J, Kwon GY, Jeon HG, Jeong BC, Seo SI, Jeon SS, Choi HY, Lee HM.
    View PubMed
  • Eur J Cancer.?2014 Jan;50(1):64-9. doi: 10.1016/j.ejca.2013.08.018. Epub 2013 Sep 20. Small tumour size is associated with new-onset chronic kidney disease after radical nephrectomy in patients with renal cell carcinoma Jeon HG11,?Choo SH1,?Sung HH1,?Jeong BC1,?Seo SI1,?Jeon SS1,?Choi HY1,?Lee HM2.
    View PubMed
  • Stem?Cells?Dev.?2013 Aug 1;22(15):2158-73. doi: 10.1089/scd.2012.0385. Epub 2013 May 3. Isolation and Characterization of Novel, Highly Proliferative Human CD34/CD73-Double-Positive Testis-Derived Stem Cells for Cell Therapy Choi WY11,?Jeon HG,?Chung Y,?Lim JJ,?Shin DH,?Kim JM,?Ki BS,?Song SH,?Choi SJ,?Park KH,?Shim SH,?Moon J,?Jung SJ,?Kang HM,?Park S,?Chung HM,?Ko JJ,Cha KY,?Yoon TK,?Kim H,?Lee DR.
    View PubMed
  • Can Urol Assoc J.?2013 May-Jun;7(5-6):193-4. doi: 10.5489/cuaj.1336. Estimating renal volume from CT: Is this is easiest way 1,Jeon HG1.
    View PubMed
  • J Urol.?2013 Apr;189(4):1249-54. doi: 10.1016/j.juro.2012.11.043. Epub 2012 Nov 13. Uric Acid Levels Correlate with Baseline Renal Function and High Levels are a Potent Risk Factor for Postoperative Chronic Kidney Disease in Patients with Renal Cell Carcinoma Jeon HG11,?Choo SH,?Jeong BC,?Seo SI,?Jeon SS,?Choi HY,?Lee HM.
    View PubMed
  • Urology. 2013 Jan;81(1):213-4. doi: 10.1016/j.urology.2012.10.002. Re: Lee et al.: Longitudinal Stone Diameter on Coronal Reconstruction of Computed Tomography as a Predictor of Ureteral Stone Expulsion in Medical Expulsive Therapy (Urology 2012;80:784-789) Reply Lee SR1, Jeon HG, Park DS, Choi YD.
    View PubMed
  • Urology. 2012 Oct;80(4):784-9. doi: 10.1016/j.urology.2012.06.032. Epub 2012 Aug 15. Longitudinal Stone Diameter on Coronal Reconstruction of Computed Tomography as a Predictor of Ureteral Stone Expulsion in Medical Expulsive Therapy Lee SR11, Jeon HG, Park DS, Choi YD.
    View PubMed